HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ronald Swanstrom Selected Research
Ronald Swanstrom Research Topics
Disease
23
Infections
10/2021 - 02/2003
6
Persistent Infection
10/2021 - 09/2011
4
HIV Infections (HIV Infection)
01/2020 - 05/2011
4
Viremia
10/2018 - 05/2008
2
Inflammation (Inflammations)
01/2020 - 05/2011
2
Body Weight (Weight, Body)
01/2020 - 09/2002
2
Neoplasms (Cancer)
11/2019 - 11/2018
2
Central Nervous System Infections (Central Nervous System Infection)
02/2014 - 01/2012
1
COVID-19
01/2020
1
Cryptococcosis
01/2020
1
Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2020
1
Urethritis
01/2020
1
Cryptococcal Meningitis
01/2020
1
Virus Diseases (Viral Diseases)
01/2019
1
Renal Cell Carcinoma (Grawitz Tumor)
11/2018
1
Latent Infection
02/2017
1
Coinfection
10/2014
1
Disease Progression
10/2014
1
Chronic Hepatitis C
10/2014
1
Human Influenza (Influenza)
03/2014
1
Dementia (Dementias)
08/2005
1
Acquired Immunodeficiency Syndrome (AIDS)
09/2002
Drug/Important Bio-Agent (IBA)
6
Vaccines
IBA
01/2016 - 02/2003
4
RNA (Ribonucleic Acid)
IBA
01/2020 - 05/2008
3
Antiviral Agents (Antivirals)
IBA
11/2019 - 10/2014
3
Amino Acids
FDA Link
01/2019 - 02/2003
3
Proteins (Proteins, Gene)
FDA Link
07/2013 - 03/2012
2
Biomarkers (Surrogate Marker)
IBA
01/2020 - 11/2018
2
Cytokines
IBA
01/2020 - 01/2020
2
molnupiravir
IBA
01/2020 - 01/2020
2
Peptide Hydrolases (Proteases)
FDA Link
01/2019 - 10/2014
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
10/2018 - 08/2009
2
env Gene Products
IBA
10/2018 - 08/2005
2
Neutralizing Antibodies
IBA
11/2014 - 04/2004
2
Viral RNA
IBA
03/2014 - 08/2010
2
Antibodies
IBA
01/2013 - 09/2011
2
Broadly Neutralizing Antibodies
IBA
01/2013 - 09/2011
2
Glycoproteins (Glycoprotein)
IBA
09/2011 - 05/2008
1
Lopinavir
FDA Link
01/2020
1
baricitinib
IBA
01/2020
1
remdesivir
IBA
01/2020
1
casirivimab and imdevimab drug combination
IBA
01/2020
1
sotrovimab
IBA
01/2020
1
nirmatrelvir and ritonavir drug combination
IBA
01/2020
1
tocilizumab (atlizumab)
FDA Link
01/2020
1
Janus Kinase Inhibitors
IBA
01/2020
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2020
1
Monoclonal Antibodies
IBA
01/2020
1
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
01/2020
1
Ivermectin (Mectizan)
FDA Link
01/2020
1
Prodrugs
IBA
01/2020
1
Interleukin-6 (Interleukin 6)
IBA
01/2020
1
Chemokines
IBA
01/2020
1
Ritonavir (Norvir)
FDA Link
01/2020
1
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
01/2020
1
Janus Kinases
IBA
01/2020
1
sarilumab
IBA
01/2020
1
Epitopes
IBA
11/2018
1
Antigens
IBA
11/2018
1
Death Domain Receptors
IBA
11/2018
1
DNA (Deoxyribonucleic Acid)
IBA
01/2016
1
Nucleotides
IBA
10/2014
1
Interferons
IBA
10/2014
1
recombinant soluble CD4
IBA
07/2013
1
AIDS Vaccines
IBA
01/2013
1
Integrase Inhibitors
IBA
08/2009
1
Anti-Infective Agents (Microbicides)
IBA
04/2008
1
Saquinavir (Invirase)
FDA Link
09/2002
1
Indinavir (Crixivan)
FDA Link
09/2002
Therapy/Procedure
10
Therapeutics
10/2021 - 08/2009
5
Art Therapy
01/2020 - 05/2011
3
Highly Active Antiretroviral Therapy (HAART)
02/2017 - 08/2009
2
Immunotherapy
01/2020 - 11/2018
1
Aftercare (After-Treatment)
01/2020
1
Withholding Treatment
10/2018
1
Salvage Therapy
09/2002